Revolutionizing the Standard of Care with Next-Generation, Cell-Free DNA Testing with Steve Chapman, Chief Executive Officer at Natera
<p>In this episode, we have the privilege of hosting the amazing Steve Chapman, Chief Executive Officer at Natera. Natera is a medical technology company specializing in cell-free DNA testing that can detect disease. Steve discusses how his company is elevating the science in the genetic testing space, especially in organ health, women's health, and oncology. He explains several distinctions of Natera's processes from the traditional standard of care and existing traditional biomarkers. He shares his thoughts on current immunotherapy procedures, value-based care, setbacks, and more.</p> <p>Click this link to the show notes, transcript, and resources: <a href="https://outcomesrocket.health/natera/2021/06/">outcomesrocket.health</a></p>
Audio is streamed directly from the publisher (pfx.vpixl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we have the privilege of hosting the amazing Steve Chapman, Chief Executive Officer at Natera. Natera is a medical technology company specializing in cell-free DNA testing that can detect disease. Steve discusses how his company is elevating the science in the genetic testing space, especially in organ health, women's health, and oncology. He explains several distinctions of Natera's processes from the traditional standard of care and existing traditional biomarkers. He shares his thoughts on current immunotherapy procedures, value-based care, setbacks, and more.
Click this link to the show notes, transcript, and resources: outcomesrocket.health